| Serial Number | 90499224 |
| Word Mark | STELLA |
| Filing Date | Saturday, January 30, 2021 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Friday, March 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of word Stella in stylized form. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, July 7, 2020 |
| First Use In Commerce Date | Tuesday, July 7, 2020 |
| Party Name | Curio Digital Therapeutics Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08540 |
| Event Date | Event Description |
| Friday, March 8, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, September 8, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, February 21, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, August 17, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, February 11, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, February 11, 2022 | LETTER OF SUSPENSION E-MAILED |
| Friday, February 11, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, February 10, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 10, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 10, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 30, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 30, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, August 30, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, August 19, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 3, 2021 | NEW APPLICATION ENTERED |